Transplant glomerulopathy: It's not always about chronic rejection

Kidney International

Volumn 80, Issue 8, 2011, Pages 801-803

  Haas, Mark ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; CARDIOLIPIN ANTIBODY; HLA ANTIGEN CLASS 2;

ANTIGEN ANTIBODY COMPLEX; CHRONIC GRAFT REJECTION; ELECTRON MICROSCOPY; ENDOTHELIUM; GLOMERULOPATHY; GLOMERULUS BASEMENT MEMBRANE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOFLUORESCENCE; KIDNEY ALLOGRAFT; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 80053535508     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.192     Document Type: Note

References (14)

1. Habib R, Zurowska A, Hinglais N et al. A specific glomerular lesion of the graft: allograft glomerulopathy. Kidney Int 1993; 44 (Suppl 42): S104-S111.
2. Cosio FG, Gloor JM, Sethi S, Stegall MD. Transplant glomerulopathy. Am J Transplant 2008; 8: 492-496. (Pubitemid 351287536)
3. Wavamunno MD, OConnell PJ, Vitalone M et al. Transplant glomerulopathy: ultrastructural abnormalities occur early in longitudinal analysis of protocol biopsies. A m J Transplant 2007; 7: 1-12.
4. Regele H, Bohmig GA, Habicht A et al. Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection. J Am Soc Nephrol 2002; 13: 2371-2380. (Pubitemid 34925248)
5. Gloor JM, Sethi S, Stegall MD et al. Transplant glomerulopathy: subclinical incidence and association with alloantibody. Am J Transplant 2007; 7: 2124-2132. (Pubitemid 47247042)
6. Sis B, Campbell PM, Muller T et al. Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause. A m J Transplant 2007; 7: 1743-1752. (Pubitemid 46905427)
7. Cosio FG, Roche Z, Agarwal A et al. Prevalence of hepatitis C in patients with idiopathic glomerulopathies in native and transplant kidneys. A m J Kidney Dis 1996; 28: 752-758. (Pubitemid 26363905)
8. Cruzado JM, Carrera M, Torras J, Grinyo JM. Hepatitis C virus infections and de novo glomerular lesions in renal allografts. A m J Transplant 2008; 1: 171-178.
9. Naesens M, Kuypers DRJ, Sarwal M. Calcineurin inhibitor nephrotoxicity. C lin J Am Soc Nephrol 2009; 4: 481-508.
10. Baid-Agrawal S, Farris III AB, Pascual M et al. Overlapping pathways to transplant glomerulopathy: chronic humoral rejection, hepatitis C infection, and thrombotic microangiopathy. K idney Int 2011; 80: 879-885.
11. Sis B, Jhangri G, Bunnag S et al. Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. A m J Transplant 2009; 9: 2312-2323.
12. Loupy A, Suberbielle-Boissel C, Hill GS et al. Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies. Am J Transplant 2009; 9: 2561-2570.
13. Baid S, Pascual M, Williams Jr WW et al. Renal thrombotic microangiopathy associated with anticardiolipin antibodies in hepatitis C-positive renal allograft recipients. J Am Soc Nephrol 1999; 10: 146-153. (Pubitemid 29034953)
14. Haas M, Mirocha J. Early ultra structural changes in renal allografts: correlation with antibody-mediated rejection and transplant glomerulopathy. A m J Transplant 2011; in press (doi: 10.1111/j.1600-6143.2011.03647.x)